| Novel Modulators of the Growth Hormone - Insulin-Like Growth Factor Axis: Pregnancy-Associated Plasma Protein-A2 and Stanniocalcin-2 | Masanobu FUJİMOTO,Vivian HWA,Andrew DAUBER | 1–8 |
| Latest Insights on the Etiology and Management of Primary Adrenal Insufficiency in Children | Tülay GÜRAN | 9–22 |
| The Rationale for Growth Hormone Therapy in Children with Short Stature | Annalisa DEODATİ,Stefano CİANFARANİ | 23–32 |
| A Critical Appraisal of the Effect of Gonadotropin-Releasing Hormon Analog Treatment on Adult Height of Girls with Central Precocious Puberty | Abdullah BEREKET | 33–48 |
| Insulin Resistance, Prediabetes, Metabolic Syndrome: What Should Every Pediatrician Know? | Ahmad IGHBARİYA,Ram WEİSS | 49–57 |
| Current Nomenclature of Pseudohypoparathyroidism: Inactivating Parathyroid Hormone/Parathyroid Hormone-Related Protein Signaling Disorder | Serap TURAN | 58–68 |
| Congenital Hyperinsulinism: Diagnosis and Treatment Update | Hüseyin DEMİRBİLEK,Khalid HUSSAIN | 69–87 |
| Genetic Causes of Rickets | Sezer ACAR,KORCAN DEMİR,Yufei SHİ | 88–105 |
| Hypogonadotropic Hypogonadism due to Novel FGFR1 Mutations | GAMZE AKKUŞ,LEMAN DAMLA KOTAN GEDİK,Erdem DURMAZ,Eda MENGEN,İHSAN TURAN,Ayça ULUBAY,FATİH GÜRBÜZ,BİLGİN YÜKSEL,BEKİR TAMER TETİKER,A. Kemal TOPALOĞLU | 95–100 |
| Basal Serum Neurokinin B Levels in Differentiating Idiopathic Central Precocious Puberty from Premature Thelarche | Mesut PARLAK,DOĞA TÜRKKAHRAMAN,Hamit Yaşar ELLİDAĞ,Gamze ÇELMELİ,Ayşe Eda PARLAK,Necat YILMAZ | 101–105 |
| Congenital Hypothyroidism and Bone Remodeling Cycle | NAZMİ MUTLU KARAKAŞ,Sibel Tulgar KINIK,Beril ÖZDEMİR,Nursel MURATOĞLU ŞAHİN,M. Agah TEKİNDAL,Ayşegül HABERAL | 106–110 |
| Sex Assignment in Conditions Affecting Sex Development | Renata MARKOSYAN,S Faisal AHMED | 106–112 |
| Association between Obesity and Parental Weight Status in Children and Adolescents |